companydata.dkEJP PHARMACEUTICAL ApS: Financial statements 2023
CVR: 87923614
EJP PHARMACEUTICAL ApS (CVR 87923614) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -34,271 and a net result of DKK 453,582 compared with DKK -477,660 the year before. Equity amounted to DKK 4,136,712. The solvency ratio was 98.6%. The company had 1 employee in the financial year.
- Gross Profit
- -34,271 kr.
- Profit/Loss
- 453,582 kr.
- Equity
- 4,136,712 kr.
- Total Assets
- 4,194,598 kr.
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -34 t. | 454 t. | 4.1 mio. | 1 |
| 2022 | - | -49 t. | -478 t. | 6.7 mio. | 1 |
| 2021 | - | -40 t. | 443 t. | 7.3 mio. | 1 |
| 2020 | - | -75 t. | -140 t. | 6.9 mio. | 1 |
| 2019 | - | - | 566 t. | 7.6 mio. | 1 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
EJP PHARMACEUTICAL ApS has published its annual report for 2022. Gross profit came to DKK -49,225, and the net result was DKK -477,660.
About EJP PHARMACEUTICAL ApS
EJP PHARMACEUTICAL ApS is a Danish company of the type Anpartsselskab based in Skodsborg, founded in 1982. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Ejvind Jersie Pedersen. The company is owned by Ejvind Jersie Pedersen. The company has 1 employee. In 2025, the company reported a gross profit of DKK -28,266 and a net result of DKK 214,282 compared with DKK 414,071 the year before. Equity amounted to DKK 814,282.